Why Does Low Blood Sugar Cause Seizures?

The brain consumes more glucose than any other organ, and when blood sugar falls too low, neurons lose the fuel they need to maintain orderly electrical signaling. The result is a cascade of chemical disruptions that push nerve cells toward uncontrolled firing, which can ultimately produce a seizure. The pathway from low glucose to convulsions involves more than simple energy starvation, though. Shifts in neurotransmitter levels, failure of critical ion pumps, and region-specific vulnerabilities in the brain all play a role.

The Brain’s Extraordinary Appetite for Glucose

Your brain accounts for roughly two percent of your body weight but burns through about twenty percent of your total glucose supply. Unlike muscles, which can switch to burning fat when glucose is scarce, the brain relies on glucose as its primary and obligatory fuel under normal conditions.¹ Glucose doesn’t just keep the lights on. It drives the production of ATP (the molecule cells use for energy), supports the manufacture of neurotransmitters, and helps manage oxidative stress. Tight regulation of glucose metabolism is so critical that even modest disruptions can begin to impair brain function.²

This dependence means the brain is unusually vulnerable when blood sugar drops. Most other organs can compensate for a while, tapping into stored glycogen or switching fuel sources. The brain stores very little glycogen of its own and has limited ability to burn alternatives quickly enough to keep up with demand. So when circulating glucose falls below the level neurons need, trouble starts fast.

How Energy Failure Disrupts Electrical Signaling

Neurons communicate through carefully controlled electrical impulses. Maintaining that control depends on ion pumps embedded in the cell membrane, particularly the sodium-potassium pump. This pump uses ATP to shuttle sodium ions out of the cell and potassium ions in, keeping the neuron in a “ready” state between firings. When glucose drops, ATP production falls, and the sodium-potassium pump begins to fail. Without it working properly, the resting electrical potential of the neuron drifts in a direction that makes the cell easier to fire. A disruption of energy availability affects the sodium-potassium pump and the resting state potential, and it increases intracellular calcium and reactive oxygen species that promote cell death.³

This shift makes neurons progressively more excitable. Instead of waiting for proper signals, they begin firing spontaneously or in response to stimuli that would normally be too weak to trigger them. When enough neurons begin firing together in an uncoordinated burst, the result is a seizure. The process is gradual, which is why hypoglycemia typically produces a recognizable progression of symptoms: slower thinking and clumsiness give way to confusion, then loss of consciousness, then seizures, and in the worst cases, death.⁴

The Neurotransmitter Shift That Fans the Flames

Energy failure alone isn’t the whole story. As glucose drops, the brain’s chemical messaging system tips dangerously out of balance. Normally, excitatory neurotransmitters like glutamate (which encourage neurons to fire) and inhibitory neurotransmitters like GABA (which discourage firing) exist in a careful equilibrium. Hypoglycemia disrupts both sides of that balance simultaneously.

On the excitatory side, low glucose triggers the release of excess glutamate and aspartate into the spaces between neurons.⁵ At the same time, the transporters responsible for mopping up excess glutamate become less effective. Research in animal models has shown that hypoglycemia increases glutamate content while decreasing the expression of glutamate transporters, meaning glutamate lingers in the synapse longer than it should.⁶ That prolonged glutamate exposure overstimulates neighboring neurons, a process known as excitotoxicity, which both drives seizure activity and damages or kills the neurons themselves.

On the inhibitory side, GABA production falls. GABA is synthesized from glutamate by an enzyme that requires a cofactor derived from vitamin B6. During hypoglycemia, the levels of this cofactor decline, throttling GABA synthesis.⁷ Studies have documented significant decreases in GABA receptor expression and GABA binding in the cerebral cortex and hippocampus during hypoglycemia, meaning there is both less GABA being produced and fewer functional receptors to respond to whatever GABA remains.⁸ The combined effect is essentially a double hit: more excitation and less inhibition at the same time.

The Brain Burns Its Own Amino Acids for Fuel

Here’s something that makes the neurotransmitter problem even worse. When glucose runs low, the brain begins breaking down amino acids, including glutamate, GABA, and glutamine, as emergency fuel sources. These amino acids can be funneled into the energy-producing cycle that normally runs on glucose-derived molecules. This metabolic shift has been documented in research showing that during sustained hypoglycemia, concentrations of alanine, glutamate, and GABA dropped in the brain while aspartate (another excitatory amino acid) rose.⁷

The cruel irony is that the brain, in trying to keep itself alive by burning amino acids, is actually depleting the very molecules it needs to maintain normal signaling. GABA burned for energy is GABA no longer available to inhibit runaway firing. Regional studies have shown that GABA levels in the cerebral cortex fell to about 65% of normal before any visible neurological symptoms even appeared, and that marked decreases in glutamate and glutamine followed in the striatum and hippocampus.⁹ In a sense, the seizure threshold is already dropping well before a person feels noticeably impaired.

Why Some Brain Regions Are More Vulnerable

Not all parts of the brain suffer equally during a low blood sugar episode. The hippocampus, particularly the dentate gyrus and a subregion called CA1, is disproportionately susceptible to hypoglycemic damage. The cerebral cortex also takes a significant hit. In animal studies, severe hypoglycemia produced extensive neuronal death in these hippocampal regions, and there was a striking correlation between neuronal damage and the occurrence of seizure-like activity.¹⁰

The hippocampus is the brain’s memory-processing center, which helps explain why repeated severe hypoglycemia can lead to lasting problems with memory and cognition. The same study found that diabetic animals had more than twice as many dead neurons in the cortex as non-diabetic animals after equivalent hypoglycemic episodes, suggesting that pre-existing diabetes amplifies the damage.¹⁰ This finding has implications for anyone managing diabetes with insulin, since those patients are the ones most likely to experience severe lows repeatedly.

The hippocampus also shows particularly steep declines in GABAergic and cholinergic receptor function during hypoglycemia. Research has documented further declines in GABA receptor binding and the enzyme that produces GABA in the hippocampus of hypoglycemic animals, alongside cholinergic receptor dysfunction. The combined loss of inhibitory and modulatory signaling in this region is thought to contribute to the cognitive impairment and memory deficits reported after hypoglycemic episodes.¹¹

Why Blood Sugar Numbers Alone Don’t Predict Seizures

One frustrating clinical reality is that there’s no neat blood sugar threshold below which a seizure will reliably occur. While the general sequence of symptoms, from jitteriness and confusion to seizure to coma, is well established, the glucose level that triggers each stage varies substantially from person to person. EEG monitoring has confirmed the link between hypoglycemia and abnormal brain wave patterns, but blood glucose levels alone do not seem to predict when a person will develop neuroglycopenia, the brain-specific state of glucose deprivation.⁴

Several factors explain this variability. People who experience frequent lows may develop a blunted counterregulatory response. In diabetic patients with autonomic neuropathy, roughly two-thirds have moderate to severe deficits in their epinephrine (adrenaline) response to low blood sugar. These patients often have delayed or diminished awareness of hypoglycemia, which means their glucose can drop to dangerously low levels before they realize anything is wrong, increasing the risk of seizures and other severe complications.¹² A person with intact warning systems might feel shaky and confused at a glucose level that, in someone with impaired awareness, wouldn’t register as abnormal at all.

Local factors in the brain matter too. Certain neurons depolarize (become more excitable) in response to low external glucose through voltage-dependent mechanisms, and this response can be modulated by the metabolic state of the cell. In neurons accustomed to higher ambient glucose levels, the response may be blunted because ion channels are already in a different configuration.¹³ The interplay between systemic blood sugar, local glucose availability, and individual cellular thresholds makes the precise tipping point highly personal.

Neonatal and Pediatric Vulnerability

Newborns and young children are at heightened risk for hypoglycemic seizures, and the consequences can be more severe. The neonatal brain has higher glucose demands relative to its size, and its glycogen reserves are tiny. Conditions like prematurity, being born small for gestational age, or being the infant of a mother with diabetes can all set the stage for blood sugar drops in the first hours and days of life.

The damage pathway in neonates follows the same general pattern as in adults: neuronal depolarization triggers excessive release of glutamate and aspartate, promoting excitotoxicity, along with increased release of zinc into the extracellular space. That zinc activates a DNA repair enzyme in an overwhelming, runaway fashion that ultimately promotes neuronal death rather than repair.⁵ In addition, the chronic depletion of glycogen stored by astrocytes (the support cells that help feed neurons) further undermines the brain’s ability to buffer glucose dips.³

There’s ongoing debate about exactly what glucose level constitutes dangerous hypoglycemia in a newborn and how aggressively it should be treated. What is well established is that prolonged or repeated neonatal hypoglycemia is associated with adverse neurodevelopmental outcomes, and seizures are among the most alarming signs that the brain is being injured.

Diabetes, Recurrent Lows, and Lowered Seizure Thresholds

People with diabetes, particularly those using insulin, are the most common group to experience hypoglycemia severe enough to provoke seizures. Insulin lowers blood sugar by design, and miscalculating a dose, skipping a meal, or exercising more than planned can push glucose below safe levels. What makes repeated episodes particularly dangerous is that each severe low may make the next one more likely to cause a seizure.

Research in juvenile diabetic animal models has shown that recurrent hypoglycemic episodes impair the body’s counterregulatory responses, which are the hormonal defenses that normally kick in to raise blood sugar when it drops too far. That impairment may lower the seizure threshold over time, meaning a less severe drop can trigger convulsions than would have been necessary initially.¹⁴ Seizure severity in these models was also strongly associated with mortality. The implication for patients managing diabetes is clear: preventing severe lows matters not just for comfort but for long-term brain safety.

Pre-existing diabetes also appears to amplify the brain damage from any given hypoglycemic episode. As noted in regional brain studies, diabetic animals showed more than double the cortical neuron death compared to non-diabetic animals exposed to the same degree of low blood sugar.¹⁰ The mechanisms likely involve chronic changes in GABA and glutamate receptor expression that leave the diabetic brain already partially primed for excitotoxic injury before the hypoglycemia even starts.⁸

When the Cause Isn’t Diabetes

Hypoglycemic seizures can also occur in people without diabetes, and in those cases the underlying cause can be harder to identify. One instructive example involves insulinomas, rare tumors of the pancreas that secrete insulin independently of blood sugar levels. Because the excess insulin drives glucose unpredictably low, the symptoms can masquerade as epilepsy.

A published case describes a woman in her sixties who presented with recurrent episodes of confusion and double vision that resolved spontaneously within about ten minutes. She was initially diagnosed with complex partial seizures and started on an anti-seizure medication. Only when she returned the following week with a recurrence, this time with a recorded blood glucose of just 1.9 mmol/L (about 34 mg/dL), was the true cause identified: an insulinoma producing elevated insulin levels even as her blood sugar plummeted.¹⁵ Cases like this highlight that checking blood glucose should be a reflex whenever a patient presents with new seizure-like episodes, especially when the events are brief, stereotyped, and associated with confusion.

Other non-diabetic causes of hypoglycemia that can reach seizure territory include excessive alcohol intake (which impairs the liver’s ability to release stored glucose), certain medications, adrenal insufficiency, and, rarely, large tumors that consume glucose or produce insulin-like hormones. In each case, the downstream effect on the brain follows the same pathway: glucose deprivation, ion pump failure, neurotransmitter imbalance, and hyperexcitability.

What Happens During Treatment

When someone is seizing from low blood sugar, the immediate priority is getting glucose into the bloodstream. If the person is conscious and able to swallow, fast-acting sugar by mouth is the simplest approach: glucose tablets, juice, or regular soda. But seizures and severe hypoglycemia often make swallowing unsafe.

For patients who cannot take anything by mouth due to unconsciousness, seizures, or altered mental status, emergency treatment typically involves intravenous dextrose, a concentrated glucose solution. Glucagon, the body’s main counter-regulatory hormone to insulin, is the other first-line option. Glucagon works by signaling the liver to break down its glycogen stores and release glucose into the bloodstream. It can be injected intramuscularly or administered nasally, making it usable by bystanders before medical help arrives.¹⁶

Glucagon has a limitation: it depends on the liver having glycogen to release. In someone who is malnourished, has been fasting for a long time, or has been drinking heavily, glycogen stores may be depleted, and glucagon won’t work as well. In those situations, IV dextrose is the definitive treatment. Once blood sugar rises, seizure activity typically stops, though the person may remain confused or drowsy for a period afterward. The brain needs time to re-establish its normal electrochemical environment, and any neuronal damage that occurred during the episode doesn’t reverse with glucose replacement.

The Role of Astrocytes

Neurons get most of the attention in discussions of hypoglycemic seizures, but they aren’t working alone. Astrocytes, star-shaped glial cells that vastly outnumber neurons, play a critical support role in brain energy metabolism. They store small amounts of glycogen, shuttle fuel to neurons, and help regulate the concentration of neurotransmitters like glutamate in the synaptic space. The metabolic coupling between neurons and astrocytes is especially relevant during glucose deprivation, because astrocytes can briefly supply neurons with lactate derived from their glycogen reserves, acting as a short-term buffer.¹⁷

When hypoglycemia persists, however, astrocyte glycogen is quickly exhausted. Chronic or recurrent low blood sugar can reduce the amount of glycogen astrocytes store going forward, shrinking this safety buffer for future episodes.³ Astrocytes are also key to clearing excess glutamate from the synapse. When they run out of energy, glutamate removal slows, amplifying the excitotoxic cascade. So the failure of astrocyte support functions compounds the problems neurons are already facing from direct glucose starvation, turning a bad situation into a dangerous one.

Distinguishing Hypoglycemic Seizures from Epilepsy

Because hypoglycemic seizures can look identical to epileptic seizures, including the same generalized tonic-clonic (formerly “grand mal”) movements, they are sometimes misdiagnosed as epilepsy. The insulinoma case described earlier is a textbook example. The key difference is that hypoglycemic seizures are a symptom of a metabolic problem, not a primary brain disorder. Treating them with anti-seizure medications without addressing the underlying glucose issue won’t prevent recurrence and may delay the real diagnosis.

Several features can raise suspicion that a seizure is metabolic rather than epileptic. Seizures that occur in the early morning (when fasting glucose is lowest), that are preceded by sweating, tremors, or palpitations, or that occur in someone with known diabetes or other metabolic risk factors should prompt a blood glucose check. In clinical settings, routine EEG patterns during hypoglycemia show a characteristic progression from normal rhythms to slowing, then to burst-suppression patterns, and finally to electrical silence if glucose falls far enough.⁴ This pattern differs from the spike-and-wave discharges typical of many forms of epilepsy, though in practice the distinction usually rests on measuring blood glucose at the time of the event rather than on EEG interpretation alone.